BACKGROUND: Mitosis is a highly regulated process that serves to ensure the fidelity of cell division. The disruption of mitotic regulators leading to aneuploidy and polyploidy is commonly observed in cancer cells. Single nucleotide polymorphisms (SNP) in regulators of mitosis may promote chromosome missegregation and influence pancreatic cancer and/or survival. METHODS: Thirty-four SNPs, previously associated with breast cancer risk, from 33 genes involved in the regulation of mitosis, were investigated for associations with pancreatic cancer risk in 1,143 Caucasian patients with pancreatic adenocarcinoma and 1,097 unaffected controls from the Mayo Clinic. Associations with survival from pancreatic cancer were also assessed using 1,030 pancreatic cancer cases with known outcome. RESULTS: Two SNPs in the APC (rs2431238) and NIN (rs10145182) loci, of 34 examined, were significantly associated with pancreatic cancer risk (P = 0.035 and P = 0.038, respectively). Further analyses of individuals categorized by smoking and body mass index identified several SNPs displaying significant associations (P < 0.05) with pancreatic cancer risk, including APC rs2431238 in individuals with high body mass index (>/=30; P = 0.031) and NIN rs10145182 in ever smokers (P = 0.01). In addition, survival analyses detected significant associations between SNPs in EIF3S10 and overall survival (P = 0.009), SNPs from five genes and survival in resected cancer cases (P < 0.05), and SNPs from two other genes (P < 0.05) and survival of locally advanced cancer cases. CONCLUSION: Common variation in genes encoding regulators of mitosis may independently influence pancreatic cancer susceptibility and survival.
BACKGROUND: Mitosis is a highly regulated process that serves to ensure the fidelity of cell division. The disruption of mitotic regulators leading to aneuploidy and polyploidy is commonly observed in cancer cells. Single nucleotide polymorphisms (SNP) in regulators of mitosis may promote chromosome missegregation and influence pancreatic cancer and/or survival. METHODS: Thirty-four SNPs, previously associated with breast cancer risk, from 33 genes involved in the regulation of mitosis, were investigated for associations with pancreatic cancer risk in 1,143 Caucasian patients with pancreatic adenocarcinoma and 1,097 unaffected controls from the Mayo Clinic. Associations with survival from pancreatic cancer were also assessed using 1,030 pancreatic cancer cases with known outcome. RESULTS: Two SNPs in the APC (rs2431238) and NIN (rs10145182) loci, of 34 examined, were significantly associated with pancreatic cancer risk (P = 0.035 and P = 0.038, respectively). Further analyses of individuals categorized by smoking and body mass index identified several SNPs displaying significant associations (P < 0.05) with pancreatic cancer risk, including APCrs2431238 in individuals with high body mass index (>/=30; P = 0.031) and NINrs10145182 in ever smokers (P = 0.01). In addition, survival analyses detected significant associations between SNPs in EIF3S10 and overall survival (P = 0.009), SNPs from five genes and survival in resected cancer cases (P < 0.05), and SNPs from two other genes (P < 0.05) and survival of locally advanced cancer cases. CONCLUSION: Common variation in genes encoding regulators of mitosis may independently influence pancreatic cancer susceptibility and survival.
Authors: M Bettencourt-Dias; R Giet; R Sinka; A Mazumdar; W G Lock; F Balloux; P J Zafiropoulos; S Yamaguchi; S Winter; R W Carthew; M Cooper; D Jones; L Frenz; D M Glover Journal: Nature Date: 2004-12-23 Impact factor: 49.962
Authors: A M Goldstein; M C Fraser; J P Struewing; C J Hussussian; K Ranade; D P Zametkin; L S Fontaine; S M Organic; N C Dracopoli; W H Clark Journal: N Engl J Med Date: 1995-10-12 Impact factor: 91.245
Authors: Jason A Willis; Sara H Olson; Irene Orlow; Semanti Mukherjee; Robert R McWilliams; Robert C Kurtz; Robert J Klein Journal: Clin Cancer Res Date: 2012-06-04 Impact factor: 12.531
Authors: Xiaozheng Kang; Hongliang Liu; Mark W Onaitis; Zhensheng Liu; Kouros Owzar; Younghun Han; Li Su; Yongyue Wei; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeböller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria Teresa Landi; Joachim Heinrich; Angela Risch; Xifeng Wu; Yuanqing Ye; David C Christiani; Christopher I Amos; Qingyi Wei Journal: Carcinogenesis Date: 2016-02-10 Impact factor: 4.944
Authors: Angela J Frank; Chau-Chyun Sheu; Yang Zhao; Feng Chen; Li Su; Michelle N Gong; Ednan Bajwa; B Taylor Thompson; David C Christiani Journal: Crit Care Med Date: 2012-07 Impact factor: 7.598
Authors: Samuel O Antwi; William R Bamlet; Richard M Cawthon; Kari G Rabe; Brooke R Druliner; Hugues Sicotte; Aminah Jatoi; Amit Mahipal; Lisa A Boardman; Ann L Oberg; Gloria M Petersen Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-11-13 Impact factor: 4.090
Authors: Chen Wu; Peter Kraft; Rachael Stolzenberg-Solomon; Emily Steplowski; Michelle Brotzman; Mousheng Xu; Poorva Mudgal; Laufey Amundadottir; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Charles Kooperberg; Gloria M Petersen; Wei Zheng; Demetrius Albanes; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Guangwen Cao; Eric J Duell; Joanne W Elena; J Michael Gaziano; Edward L Giovannucci; Goran Hallmans; Amy Hutchinson; David J Hunter; Mazda Jenab; Guoliang Jiang; Kay-Tee Khaw; Andrea LaCroix; Zhaoshen Li; Julie B Mendelsohn; Salvatore Panico; Alpa V Patel; Zhi Rong Qian; Elio Riboli; Howard Sesso; Hongbing Shen; Xiao-Ou Shu; Anne Tjonneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Jarmo Virtamo; Kala Visvanathan; Jean Wactawski-Wende; Chengfeng Wang; Kai Yu; Anne Zeleniuch-Jacquotte; Stephen Chanock; Robert Hoover; Patricia Hartge; Charles S Fuchs; Dongxin Lin; Brian M Wolpin Journal: Gut Date: 2012-11-24 Impact factor: 23.059